Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.
about
Matrix Metalloproteinases in Non-Neoplastic Disorders.The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosisMultifaceted role of matrix metalloproteinases (MMPs)Role of platelets in neuroinflammation: a wide-angle perspectiveMMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neuronsMyelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosisContributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction.Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis.Binswanger's disease: toward a diagnosis agreement and therapeutic approachCleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis.Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapiesInhibition of myelin-cleaving poteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-IIEstrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease.Th17 cells in human disease.Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodiesCXCR2 signaling and host defense following coronavirus-induced encephalomyelitis.A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosisMatrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.Immunomodulation by transplanted human embryonic stem cell-derived oligodendroglial progenitors in experimental autoimmune encephalomyelitis.Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation.Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation.Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis PatientsTight junction proteins expression and modulation in immune cells and multiple sclerosisCathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosisBowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.Role of extracellular factors in axon regeneration in the CNS: implications for therapy.Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.Serum levels of matrix metalloproteinases: implications in clinical neurology.Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders.Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury.MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.
P2860
Q26741827-484C1D76-FA50-489F-BAC1-641E781FDB20Q27009126-3151D875-1101-496E-84A7-24F63D89BB23Q28083906-850429C0-1206-46FF-848B-DB96618619DDQ28393808-5D4DA2C2-E05E-4756-A6CE-98FB556C7266Q28482213-F600B6AF-506C-45DD-B3FB-BF509D2B2698Q28910423-52031EF5-2FE6-4A55-96DC-BD6B0042A974Q30483239-0FD45D5D-9109-4D98-A655-EEE2B2D7FCD9Q30486651-A9D575FA-7EC1-407D-91F8-51B40F4606FFQ30848732-011EDA09-EC03-4E70-B60D-DD107DFF84FCQ34086999-330E1C22-C4D2-4939-A478-229622D86FD0Q34136881-0D1B6CAF-56BA-4E36-9D0E-BEED35F0F9C4Q34512363-2707ABDC-344D-41C9-8395-CDDD67E481A9Q34579845-0EDF5D98-BDC8-4858-8A7A-DD70B2388C8BQ34610688-D0E937B0-94A4-450E-89B2-FEA060A3FB4DQ34768858-A59D9267-8E6C-4946-85A1-26603652925BQ35007289-114D7842-D06B-45EC-82EF-153594225EADQ35012792-F1397FBE-F84E-4138-AEC4-8AA1C2914150Q35820734-B878507F-0C07-4D58-9099-3DC784483B10Q35880955-9A6D6DB7-A644-48BC-9EC4-0E4416E23054Q35947646-EF133EF9-9A49-4309-B62C-795DCB82AC1EQ36175816-B444D67F-4648-4D49-BFA8-FED99AD460A9Q36210614-B8EAE4E5-69F2-483F-8DF4-8F876FFC2AA2Q36802161-7C28ED25-C028-4D99-B199-FA7082633E4CQ36838582-A22BE783-3866-4451-8E20-E965F3468FB0Q37009992-735D1F6D-D613-4D01-9264-23A1E78E35CFQ37150788-94E66B72-348B-485D-A58C-6ECB3FDC7AFAQ37171985-36BB50CA-1736-4D06-A19E-551052B2707EQ37294615-4CAD8447-F9D1-47E8-958C-973F783D7F89Q37294866-1CF445CD-690D-40DD-8734-1B0CC1424B80Q37297572-E6D990A1-F14C-4DE6-A112-4FEEC38ABC65Q37306814-96196177-221F-432E-8A27-AB817991C61EQ37456857-7457625C-88DE-4C73-B41B-FFC134D03E3AQ37484777-40453DE1-8F62-4846-8854-4F5391690D3CQ37584887-70C20E64-83B4-48FB-909D-5DF315DE4C00Q37595298-76774AB5-9322-4012-9869-F6F1A83A0715Q37977361-3A3EA75B-D7A6-437C-9331-53348A9BB547Q38134015-2D8575E5-8E8A-473C-B849-8D72B162C0D2Q38151704-A5725F02-54FE-4918-A00F-02F73435D015Q38248004-D7AC2816-9FC5-49D1-BD2F-B28943DFE6C0Q38622769-2A694F35-ACB7-4C8E-81B6-9D710D6A271F
P2860
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@ast
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@en
type
label
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@ast
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@en
prefLabel
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@ast
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@en
P2093
P1476
Elevation of matrix metallopro ...... nd impact of immunomodulators.
@en
P2093
Angelika Goncalves Dasilva
Luanne M Metz
Rana K Zabad
Smriti Agrawal
V Wee Yong
P356
10.1016/J.JNS.2006.11.021
P577
2007-03-23T00:00:00Z